世界の抗狂犬病血清市場予測 2023年-2029年

【英語タイトル】Global Anti Rabies Serum Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC02437)・商品コード:LP23DC02437
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗狂犬病血清市場」は、過去の販売実績から2022年の世界の抗狂犬病血清の総販売量を検討し、2023年から2029年の予測される抗狂犬病血清の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗狂犬病血清の市場規模を掲載し、XXX百万米ドル規模の世界の抗狂犬病血清市場の詳細な分析を提供します。本インサイトレポートは、世界の抗狂犬病血清業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗狂犬病血清市場における各社の独自のポジションをより深く理解するために、抗狂犬病血清製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗狂犬病血清市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗狂犬病血清の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。抗狂犬病血清の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗狂犬病血清のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗狂犬病血清の世界主要メーカーとしては、Haffkine Ajintha Pharmaceuticals、 Bharat Serums and Vaccines、 National Institutes of Health、 Congruent Pharmachem、 Shanghai Serum Bio-technology、 Serum Institute of India、 Premium Serums、 LEXICARE PHARMA、 Zydus Cadila Healthcare、 VINS Bio-Products、 Zydus Takeda Healthcare、 BPL、 Aventis Pasteurなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗狂犬病血清市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗狂犬病血清市場をセグメンテーションし、種類別 (ヒト抗狂犬病免疫グロブリン、ウマ抗狂犬病免疫グロブリン)、用途別 (診療所、病院)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:ヒト抗狂犬病免疫グロブリン、ウマ抗狂犬病免疫グロブリン

・用途別区分:診療所、病院

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の抗狂犬病血清市場の10年間の市場状況・展望は?
・世界および地域別に見た抗狂犬病血清市場成長の要因は何か?
・抗狂犬病血清の市場機会はエンドマーケットの規模によってどのように変化するのか?
・抗狂犬病血清のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:抗狂犬病血清の年間販売量2018-2029、地域別現状・将来分析
・抗狂犬病血清の種類別セグメント:ヒト抗狂犬病免疫グロブリン、ウマ抗狂犬病免疫グロブリン
・抗狂犬病血清の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・抗狂犬病血清の用途別セグメント:診療所、病院
・抗狂犬病血清の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗狂犬病血清市場
・企業別のグローバル抗狂犬病血清市場データ:2018-2023年の年間販売量、市場シェア
・企業別の抗狂犬病血清の年間売上:2018-2023年の売上、市場シェア
・企業別の抗狂犬病血清販売価格
・主要企業の抗狂犬病血清生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗狂犬病血清の地域別レビュー
・地域別の抗狂犬病血清市場規模2018-2023:年間販売量、売上
・主要国別の抗狂犬病血清市場規模2018-2023:年間販売量、売上
・南北アメリカの抗狂犬病血清販売の成長
・アジア太平洋の抗狂犬病血清販売の成長
・ヨーロッパの抗狂犬病血清販売の成長
・中東・アフリカの抗狂犬病血清販売の成長

南北アメリカ市場
・南北アメリカの国別の抗狂犬病血清販売量、売上(2018-2023)
・南北アメリカの抗狂犬病血清の種類別販売量
・南北アメリカの抗狂犬病血清の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗狂犬病血清販売量、売上(2018-2023)
・アジア太平洋の抗狂犬病血清の種類別販売量
・アジア太平洋の抗狂犬病血清の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗狂犬病血清販売量、売上(2018-2023)
・ヨーロッパの抗狂犬病血清の種類別販売量
・ヨーロッパの抗狂犬病血清の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗狂犬病血清販売量、売上(2018-2023)
・中東・アフリカの抗狂犬病血清の種類別販売量
・中東・アフリカの抗狂犬病血清の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗狂犬病血清の製造コスト構造分析
・抗狂犬病血清の製造プロセス分析
・抗狂犬病血清の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・抗狂犬病血清の主要なグローバル販売業者
・抗狂犬病血清の主要なグローバル顧客

地域別の抗狂犬病血清市場予測レビュー
・地域別の抗狂犬病血清市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗狂犬病血清の種類別市場規模予測
・抗狂犬病血清の用途別市場規模予測

主要企業分析
Haffkine Ajintha Pharmaceuticals、 Bharat Serums and Vaccines、 National Institutes of Health、 Congruent Pharmachem、 Shanghai Serum Bio-technology、 Serum Institute of India、 Premium Serums、 LEXICARE PHARMA、 Zydus Cadila Healthcare、 VINS Bio-Products、 Zydus Takeda Healthcare、 BPL、 Aventis Pasteur
・企業情報
・抗狂犬病血清製品
・抗狂犬病血清販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anti Rabies Serum market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Anti-rabies serum is a biological product that is used to prevent and treat rabies infection. It is made from the blood of animals that have been immunized against the rabies virus. The serum contains antibodies that can neutralize the virus and prevent it from causing disease.

The development prospects of anti-rabies serum are promising. Advances in biotechnology and immunology have led to the development of new techniques for producing and purifying antibodies. These techniques have made it possible to produce high-quality anti-rabies serum that is safe and effective.

In addition, there is a growing demand for anti-rabies serum in many parts of the world, particularly in developing countries where rabies is still a major public health problem. This demand has led to increased investment in research and development of new anti-rabies serum products.
LPI (LP Information)’ newest research report, the “Anti Rabies Serum Industry Forecast” looks at past sales and reviews total world Anti Rabies Serum sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti Rabies Serum sales for 2023 through 2029. With Anti Rabies Serum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti Rabies Serum industry.
This Insight Report provides a comprehensive analysis of the global Anti Rabies Serum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti Rabies Serum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti Rabies Serum market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti Rabies Serum and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti Rabies Serum.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti Rabies Serum market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Human Anti-rabies Immunoglobulin
Equine Anti-rabies Immunoglobulin
Segmentation by application
Clinic
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Haffkine Ajintha Pharmaceuticals
Bharat Serums and Vaccines
National Institutes of Health
Congruent Pharmachem
Shanghai Serum Bio-technology
Serum Institute of India
Premium Serums
LEXICARE PHARMA
Zydus Cadila Healthcare
VINS Bio-Products
Zydus Takeda Healthcare
BPL
Aventis Pasteur
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti Rabies Serum market?
What factors are driving Anti Rabies Serum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti Rabies Serum market opportunities vary by end market size?
How does Anti Rabies Serum break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti Rabies Serum Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti Rabies Serum by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti Rabies Serum by Country/Region, 2018, 2022 & 2029
2.2 Anti Rabies Serum Segment by Type
2.2.1 Human Anti-rabies Immunoglobulin
2.2.2 Equine Anti-rabies Immunoglobulin
2.3 Anti Rabies Serum Sales by Type
2.3.1 Global Anti Rabies Serum Sales Market Share by Type (2018-2023)
2.3.2 Global Anti Rabies Serum Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti Rabies Serum Sale Price by Type (2018-2023)
2.4 Anti Rabies Serum Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.5 Anti Rabies Serum Sales by Application
2.5.1 Global Anti Rabies Serum Sale Market Share by Application (2018-2023)
2.5.2 Global Anti Rabies Serum Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti Rabies Serum Sale Price by Application (2018-2023)
3 Global Anti Rabies Serum by Company
3.1 Global Anti Rabies Serum Breakdown Data by Company
3.1.1 Global Anti Rabies Serum Annual Sales by Company (2018-2023)
3.1.2 Global Anti Rabies Serum Sales Market Share by Company (2018-2023)
3.2 Global Anti Rabies Serum Annual Revenue by Company (2018-2023)
3.2.1 Global Anti Rabies Serum Revenue by Company (2018-2023)
3.2.2 Global Anti Rabies Serum Revenue Market Share by Company (2018-2023)
3.3 Global Anti Rabies Serum Sale Price by Company
3.4 Key Manufacturers Anti Rabies Serum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti Rabies Serum Product Location Distribution
3.4.2 Players Anti Rabies Serum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti Rabies Serum by Geographic Region
4.1 World Historic Anti Rabies Serum Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti Rabies Serum Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti Rabies Serum Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti Rabies Serum Market Size by Country/Region (2018-2023)
4.2.1 Global Anti Rabies Serum Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti Rabies Serum Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti Rabies Serum Sales Growth
4.4 APAC Anti Rabies Serum Sales Growth
4.5 Europe Anti Rabies Serum Sales Growth
4.6 Middle East & Africa Anti Rabies Serum Sales Growth
5 Americas
5.1 Americas Anti Rabies Serum Sales by Country
5.1.1 Americas Anti Rabies Serum Sales by Country (2018-2023)
5.1.2 Americas Anti Rabies Serum Revenue by Country (2018-2023)
5.2 Americas Anti Rabies Serum Sales by Type
5.3 Americas Anti Rabies Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti Rabies Serum Sales by Region
6.1.1 APAC Anti Rabies Serum Sales by Region (2018-2023)
6.1.2 APAC Anti Rabies Serum Revenue by Region (2018-2023)
6.2 APAC Anti Rabies Serum Sales by Type
6.3 APAC Anti Rabies Serum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti Rabies Serum by Country
7.1.1 Europe Anti Rabies Serum Sales by Country (2018-2023)
7.1.2 Europe Anti Rabies Serum Revenue by Country (2018-2023)
7.2 Europe Anti Rabies Serum Sales by Type
7.3 Europe Anti Rabies Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti Rabies Serum by Country
8.1.1 Middle East & Africa Anti Rabies Serum Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti Rabies Serum Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti Rabies Serum Sales by Type
8.3 Middle East & Africa Anti Rabies Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti Rabies Serum
10.3 Manufacturing Process Analysis of Anti Rabies Serum
10.4 Industry Chain Structure of Anti Rabies Serum
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti Rabies Serum Distributors
11.3 Anti Rabies Serum Customer
12 World Forecast Review for Anti Rabies Serum by Geographic Region
12.1 Global Anti Rabies Serum Market Size Forecast by Region
12.1.1 Global Anti Rabies Serum Forecast by Region (2024-2029)
12.1.2 Global Anti Rabies Serum Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti Rabies Serum Forecast by Type
12.7 Global Anti Rabies Serum Forecast by Application
13 Key Players Analysis
13.1 Haffkine Ajintha Pharmaceuticals
13.1.1 Haffkine Ajintha Pharmaceuticals Company Information
13.1.2 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Product Portfolios and Specifications
13.1.3 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Haffkine Ajintha Pharmaceuticals Main Business Overview
13.1.5 Haffkine Ajintha Pharmaceuticals Latest Developments
13.2 Bharat Serums and Vaccines
13.2.1 Bharat Serums and Vaccines Company Information
13.2.2 Bharat Serums and Vaccines Anti Rabies Serum Product Portfolios and Specifications
13.2.3 Bharat Serums and Vaccines Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bharat Serums and Vaccines Main Business Overview
13.2.5 Bharat Serums and Vaccines Latest Developments
13.3 National Institutes of Health
13.3.1 National Institutes of Health Company Information
13.3.2 National Institutes of Health Anti Rabies Serum Product Portfolios and Specifications
13.3.3 National Institutes of Health Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 National Institutes of Health Main Business Overview
13.3.5 National Institutes of Health Latest Developments
13.4 Congruent Pharmachem
13.4.1 Congruent Pharmachem Company Information
13.4.2 Congruent Pharmachem Anti Rabies Serum Product Portfolios and Specifications
13.4.3 Congruent Pharmachem Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Congruent Pharmachem Main Business Overview
13.4.5 Congruent Pharmachem Latest Developments
13.5 Shanghai Serum Bio-technology
13.5.1 Shanghai Serum Bio-technology Company Information
13.5.2 Shanghai Serum Bio-technology Anti Rabies Serum Product Portfolios and Specifications
13.5.3 Shanghai Serum Bio-technology Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shanghai Serum Bio-technology Main Business Overview
13.5.5 Shanghai Serum Bio-technology Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Anti Rabies Serum Product Portfolios and Specifications
13.6.3 Serum Institute of India Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Premium Serums
13.7.1 Premium Serums Company Information
13.7.2 Premium Serums Anti Rabies Serum Product Portfolios and Specifications
13.7.3 Premium Serums Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Premium Serums Main Business Overview
13.7.5 Premium Serums Latest Developments
13.8 LEXICARE PHARMA
13.8.1 LEXICARE PHARMA Company Information
13.8.2 LEXICARE PHARMA Anti Rabies Serum Product Portfolios and Specifications
13.8.3 LEXICARE PHARMA Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 LEXICARE PHARMA Main Business Overview
13.8.5 LEXICARE PHARMA Latest Developments
13.9 Zydus Cadila Healthcare
13.9.1 Zydus Cadila Healthcare Company Information
13.9.2 Zydus Cadila Healthcare Anti Rabies Serum Product Portfolios and Specifications
13.9.3 Zydus Cadila Healthcare Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Zydus Cadila Healthcare Main Business Overview
13.9.5 Zydus Cadila Healthcare Latest Developments
13.10 VINS Bio-Products
13.10.1 VINS Bio-Products Company Information
13.10.2 VINS Bio-Products Anti Rabies Serum Product Portfolios and Specifications
13.10.3 VINS Bio-Products Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 VINS Bio-Products Main Business Overview
13.10.5 VINS Bio-Products Latest Developments
13.11 Zydus Takeda Healthcare
13.11.1 Zydus Takeda Healthcare Company Information
13.11.2 Zydus Takeda Healthcare Anti Rabies Serum Product Portfolios and Specifications
13.11.3 Zydus Takeda Healthcare Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zydus Takeda Healthcare Main Business Overview
13.11.5 Zydus Takeda Healthcare Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Anti Rabies Serum Product Portfolios and Specifications
13.12.3 BPL Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Aventis Pasteur
13.13.1 Aventis Pasteur Company Information
13.13.2 Aventis Pasteur Anti Rabies Serum Product Portfolios and Specifications
13.13.3 Aventis Pasteur Anti Rabies Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aventis Pasteur Main Business Overview
13.13.5 Aventis Pasteur Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anti Rabies Serum Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti Rabies Serum Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Human Anti-rabies Immunoglobulin
Table 4. Major Players of Equine Anti-rabies Immunoglobulin
Table 5. Global Anti Rabies Serum Sales by Type (2018-2023) & (K Units)
Table 6. Global Anti Rabies Serum Sales Market Share by Type (2018-2023)
Table 7. Global Anti Rabies Serum Revenue by Type (2018-2023) & ($ million)
Table 8. Global Anti Rabies Serum Revenue Market Share by Type (2018-2023)
Table 9. Global Anti Rabies Serum Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Anti Rabies Serum Sales by Application (2018-2023) & (K Units)
Table 11. Global Anti Rabies Serum Sales Market Share by Application (2018-2023)
Table 12. Global Anti Rabies Serum Revenue by Application (2018-2023)
Table 13. Global Anti Rabies Serum Revenue Market Share by Application (2018-2023)
Table 14. Global Anti Rabies Serum Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Anti Rabies Serum Sales by Company (2018-2023) & (K Units)
Table 16. Global Anti Rabies Serum Sales Market Share by Company (2018-2023)
Table 17. Global Anti Rabies Serum Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Anti Rabies Serum Revenue Market Share by Company (2018-2023)
Table 19. Global Anti Rabies Serum Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Anti Rabies Serum Producing Area Distribution and Sales Area
Table 21. Players Anti Rabies Serum Products Offered
Table 22. Anti Rabies Serum Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti Rabies Serum Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Anti Rabies Serum Sales Market Share Geographic Region (2018-2023)
Table 27. Global Anti Rabies Serum Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Anti Rabies Serum Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Anti Rabies Serum Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Anti Rabies Serum Sales Market Share by Country/Region (2018-2023)
Table 31. Global Anti Rabies Serum Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Anti Rabies Serum Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Anti Rabies Serum Sales by Country (2018-2023) & (K Units)
Table 34. Americas Anti Rabies Serum Sales Market Share by Country (2018-2023)
Table 35. Americas Anti Rabies Serum Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Anti Rabies Serum Revenue Market Share by Country (2018-2023)
Table 37. Americas Anti Rabies Serum Sales by Type (2018-2023) & (K Units)
Table 38. Americas Anti Rabies Serum Sales by Application (2018-2023) & (K Units)
Table 39. APAC Anti Rabies Serum Sales by Region (2018-2023) & (K Units)
Table 40. APAC Anti Rabies Serum Sales Market Share by Region (2018-2023)
Table 41. APAC Anti Rabies Serum Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Anti Rabies Serum Revenue Market Share by Region (2018-2023)
Table 43. APAC Anti Rabies Serum Sales by Type (2018-2023) & (K Units)
Table 44. APAC Anti Rabies Serum Sales by Application (2018-2023) & (K Units)
Table 45. Europe Anti Rabies Serum Sales by Country (2018-2023) & (K Units)
Table 46. Europe Anti Rabies Serum Sales Market Share by Country (2018-2023)
Table 47. Europe Anti Rabies Serum Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Anti Rabies Serum Revenue Market Share by Country (2018-2023)
Table 49. Europe Anti Rabies Serum Sales by Type (2018-2023) & (K Units)
Table 50. Europe Anti Rabies Serum Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Anti Rabies Serum Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Anti Rabies Serum Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Anti Rabies Serum Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Anti Rabies Serum Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti Rabies Serum Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Anti Rabies Serum Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Anti Rabies Serum
Table 58. Key Market Challenges & Risks of Anti Rabies Serum
Table 59. Key Industry Trends of Anti Rabies Serum
Table 60. Anti Rabies Serum Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Anti Rabies Serum Distributors List
Table 63. Anti Rabies Serum Customer List
Table 64. Global Anti Rabies Serum Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Anti Rabies Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Anti Rabies Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Anti Rabies Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Anti Rabies Serum Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Anti Rabies Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Anti Rabies Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Anti Rabies Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Anti Rabies Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Anti Rabies Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Anti Rabies Serum Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Anti Rabies Serum Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Anti Rabies Serum Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Anti Rabies Serum Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Haffkine Ajintha Pharmaceuticals Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 79. Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Product Portfolios and Specifications
Table 80. Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Haffkine Ajintha Pharmaceuticals Main Business
Table 82. Haffkine Ajintha Pharmaceuticals Latest Developments
Table 83. Bharat Serums and Vaccines Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 84. Bharat Serums and Vaccines Anti Rabies Serum Product Portfolios and Specifications
Table 85. Bharat Serums and Vaccines Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bharat Serums and Vaccines Main Business
Table 87. Bharat Serums and Vaccines Latest Developments
Table 88. National Institutes of Health Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 89. National Institutes of Health Anti Rabies Serum Product Portfolios and Specifications
Table 90. National Institutes of Health Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. National Institutes of Health Main Business
Table 92. National Institutes of Health Latest Developments
Table 93. Congruent Pharmachem Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 94. Congruent Pharmachem Anti Rabies Serum Product Portfolios and Specifications
Table 95. Congruent Pharmachem Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Congruent Pharmachem Main Business
Table 97. Congruent Pharmachem Latest Developments
Table 98. Shanghai Serum Bio-technology Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 99. Shanghai Serum Bio-technology Anti Rabies Serum Product Portfolios and Specifications
Table 100. Shanghai Serum Bio-technology Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Shanghai Serum Bio-technology Main Business
Table 102. Shanghai Serum Bio-technology Latest Developments
Table 103. Serum Institute of India Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 104. Serum Institute of India Anti Rabies Serum Product Portfolios and Specifications
Table 105. Serum Institute of India Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Serum Institute of India Main Business
Table 107. Serum Institute of India Latest Developments
Table 108. Premium Serums Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 109. Premium Serums Anti Rabies Serum Product Portfolios and Specifications
Table 110. Premium Serums Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Premium Serums Main Business
Table 112. Premium Serums Latest Developments
Table 113. LEXICARE PHARMA Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 114. LEXICARE PHARMA Anti Rabies Serum Product Portfolios and Specifications
Table 115. LEXICARE PHARMA Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. LEXICARE PHARMA Main Business
Table 117. LEXICARE PHARMA Latest Developments
Table 118. Zydus Cadila Healthcare Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 119. Zydus Cadila Healthcare Anti Rabies Serum Product Portfolios and Specifications
Table 120. Zydus Cadila Healthcare Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Zydus Cadila Healthcare Main Business
Table 122. Zydus Cadila Healthcare Latest Developments
Table 123. VINS Bio-Products Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 124. VINS Bio-Products Anti Rabies Serum Product Portfolios and Specifications
Table 125. VINS Bio-Products Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. VINS Bio-Products Main Business
Table 127. VINS Bio-Products Latest Developments
Table 128. Zydus Takeda Healthcare Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 129. Zydus Takeda Healthcare Anti Rabies Serum Product Portfolios and Specifications
Table 130. Zydus Takeda Healthcare Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Zydus Takeda Healthcare Main Business
Table 132. Zydus Takeda Healthcare Latest Developments
Table 133. BPL Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 134. BPL Anti Rabies Serum Product Portfolios and Specifications
Table 135. BPL Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. Aventis Pasteur Basic Information, Anti Rabies Serum Manufacturing Base, Sales Area and Its Competitors
Table 139. Aventis Pasteur Anti Rabies Serum Product Portfolios and Specifications
Table 140. Aventis Pasteur Anti Rabies Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Aventis Pasteur Main Business
Table 142. Aventis Pasteur Latest Developments
List of Figures
Figure 1. Picture of Anti Rabies Serum
Figure 2. Anti Rabies Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti Rabies Serum Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti Rabies Serum Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti Rabies Serum Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Human Anti-rabies Immunoglobulin
Figure 10. Product Picture of Equine Anti-rabies Immunoglobulin
Figure 11. Global Anti Rabies Serum Sales Market Share by Type in 2022
Figure 12. Global Anti Rabies Serum Revenue Market Share by Type (2018-2023)
Figure 13. Anti Rabies Serum Consumed in Clinic
Figure 14. Global Anti Rabies Serum Market: Clinic (2018-2023) & (K Units)
Figure 15. Anti Rabies Serum Consumed in Hospital
Figure 16. Global Anti Rabies Serum Market: Hospital (2018-2023) & (K Units)
Figure 17. Global Anti Rabies Serum Sales Market Share by Application (2022)
Figure 18. Global Anti Rabies Serum Revenue Market Share by Application in 2022
Figure 19. Anti Rabies Serum Sales Market by Company in 2022 (K Units)
Figure 20. Global Anti Rabies Serum Sales Market Share by Company in 2022
Figure 21. Anti Rabies Serum Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Anti Rabies Serum Revenue Market Share by Company in 2022
Figure 23. Global Anti Rabies Serum Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Anti Rabies Serum Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Anti Rabies Serum Sales 2018-2023 (K Units)
Figure 26. Americas Anti Rabies Serum Revenue 2018-2023 ($ Millions)
Figure 27. APAC Anti Rabies Serum Sales 2018-2023 (K Units)
Figure 28. APAC Anti Rabies Serum Revenue 2018-2023 ($ Millions)
Figure 29. Europe Anti Rabies Serum Sales 2018-2023 (K Units)
Figure 30. Europe Anti Rabies Serum Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Anti Rabies Serum Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Anti Rabies Serum Revenue 2018-2023 ($ Millions)
Figure 33. Americas Anti Rabies Serum Sales Market Share by Country in 2022
Figure 34. Americas Anti Rabies Serum Revenue Market Share by Country in 2022
Figure 35. Americas Anti Rabies Serum Sales Market Share by Type (2018-2023)
Figure 36. Americas Anti Rabies Serum Sales Market Share by Application (2018-2023)
Figure 37. United States Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Anti Rabies Serum Sales Market Share by Region in 2022
Figure 42. APAC Anti Rabies Serum Revenue Market Share by Regions in 2022
Figure 43. APAC Anti Rabies Serum Sales Market Share by Type (2018-2023)
Figure 44. APAC Anti Rabies Serum Sales Market Share by Application (2018-2023)
Figure 45. China Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Anti Rabies Serum Sales Market Share by Country in 2022
Figure 53. Europe Anti Rabies Serum Revenue Market Share by Country in 2022
Figure 54. Europe Anti Rabies Serum Sales Market Share by Type (2018-2023)
Figure 55. Europe Anti Rabies Serum Sales Market Share by Application (2018-2023)
Figure 56. Germany Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Anti Rabies Serum Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Anti Rabies Serum Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Anti Rabies Serum Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Anti Rabies Serum Sales Market Share by Application (2018-2023)
Figure 65. Egypt Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Anti Rabies Serum Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Anti Rabies Serum in 2022
Figure 71. Manufacturing Process Analysis of Anti Rabies Serum
Figure 72. Industry Chain Structure of Anti Rabies Serum
Figure 73. Channels of Distribution
Figure 74. Global Anti Rabies Serum Sales Market Forecast by Region (2024-2029)
Figure 75. Global Anti Rabies Serum Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Anti Rabies Serum Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Anti Rabies Serum Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Anti Rabies Serum Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Anti Rabies Serum Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の抗狂犬病血清市場予測 2023年-2029年] (コード:LP23DC02437)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗狂犬病血清市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆